Detalles de la búsqueda
1.
Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany.
Support Care Cancer
; 20(5): 1011-21, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21562801
2.
Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer.
Onkologie
; 34(11): 614-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22104158
3.
Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.
Onkologie
; 34(5): 241-6, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21577029
4.
Cost analysis comparing an anthracycline/docetaxel regimen to CMF in patients with early stage breast cancer.
Onkologie
; 32(8-9): 473-81, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19736510
5.
Integrated IT Platform for Coordination of Diagnosis, Treatment, and Aftercare of Prosthetic Joint Infections.
In Vivo
; 33(5): 1625-1633, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471415
6.
[HERA-QUEST: HTA evaluation of generic pharmaceutical products to improve quality, economic efficiency, patient safety and transparency in drug product changes in hospitals]. / HERA-QUEST: HTA-Evaluation generischer Arzneimittel zur Verbesserung von Qualität, Oekonomie, Patientensicherheit und Transparenz bei Produktumstellungen in Kliniken.
Z Evid Fortbild Qual Gesundhwes
; 121: 5-13, 2017 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-28545614
Resultados
1 -
6
de 6
1
Próxima >
>>